PHOENIX, Jan. 27,
2025 /PRNewswire/ -- Trinity Capital
Inc. (NASDAQ: TRIN) ("Trinity Capital"), a leading alternative
asset manager, today announced the commitment of $30 million in growth capital to Elucent
Medical ("Elucent"), a pioneering medical technology company
transforming the field of guided surgical technologies.
Elucent amplifies the field of surgical guidance, transforming
standard instruments into smart tools with In-Body Spatial
Intelligence™, giving physicians true 3D surgical awareness for
unmatched precision. Based in Eden
Prairie, Minnesota, Elucent developed the
EnVisio® System, which uses a spatial field generator
measuring continuous data points across multiple planes, to display
exact 3D positioning of the SmartClip® marker and
SmartSensor™ used to guide soft-tissue surgical excision. EnVisio's
adaptive design and seamless integration redefine surgical
precision, enabling an intuitive, uninterrupted experience that
enhances precision and accuracy for better outcomes.
"Elucent is disrupting the field of surgical guidance with its
cutting-edge technology," said Lauren
Cosentino, Managing Director, Life Sciences at Trinity
Capital. "We are thrilled to be a part of Elucent's journey as they
continue to innovate and improve surgical outcomes."
"Our EnVisio® System gives surgeons confidence before, during,
and after their surgical procedures so they know they have
delivered unparalleled accuracy and precision for their patients.
We are in scale mode and are excited to partner with Trinity
Capital," said Jason Pesterfield,
CEO at Elucent. Trinity Capital's investment will be key to our
continued acceleration of our innovation and commercialization
efforts."
Earlier in 2024, Elucent raised $44.0
million in its Series C funding round. This additional
growth capital will be used to scale operations.
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN) is an international
alternative asset manager, aiming to provide investors with stable
and consistent returns through access to the private credit market.
We source, vet, and invest in dynamic privately funded
growth-oriented companies, giving our investors access to a strong
and diversified portfolio. With distinct business verticals,
Trinity Capital stands as a trusted partner for innovative
companies seeking tailored growth capital solutions. Headquartered
in Phoenix, Arizona, the firm has
an international footprint, supported by a dedicated team of
strategically located investment professionals. For more
information, visit the company's website at
trinitycapital.com and stay connected by following us on
LinkedIn and X (formerly Twitter).
About Elucent Medical:
Elucent Medical is a leading innovator in the field of guided
surgical technologies, dedicated to improving patient outcomes
through precision and accuracy. The company's flagship
technologies, EnVisio® and SmartClip®, offer
groundbreaking solutions for soft-tissue surgical guidance with
In-Body Spatial Intelligence™ (iSi). With a commitment to
innovation and collaboration, Elucent Medical is driving
advancements in surgical oncologic care, making a positive impact
on the lives of patients and the medical professionals who treat
them.
For more information about Elucent Medical and its innovative
solutions, please visit www.elucent.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-30-million-in-growth-capital-to-elucent-medical-302359966.html
SOURCE Trinity Capital Inc.
